Why the study?
Reports associating vaccinations with neurological disorders can increase vaccine hesitancy, highlighting the need to evaluate these adverse events and identify ways to understand or reduce potential risks.
Does vaccination increase the risk of neurological adverse events?
Case Report (n=1)
Does vaccination increase the risk of neurological adverse events?
While certain vaccines are associated with specific neurological adverse events like VAPP, ADEM, and FS, there is no direct evidence linking vaccination to GBS or anti-NMDARe.
OPV may rarely cause VAPP in children; leaves open confirmation of broader vaccine-related neurological risks.
Vaccination is an effective strategy to reduce the burden of preventable illness. However, many clinical reports revealed that various vaccinations may associate with neurological disorders, mainly including autoimmune disease, febrile seizure, and vaccine-associated paralytic poliomyelitis (VAPP). Although more and more reports revealed that part of the above post-vaccine neurological disorders is not directly related to vaccination, it may be merely a coincidence. However, these reports may increase the hesitancy on vaccination for the public population and influence the coverage of vaccination. In this report, we described a child with acute flaccid paralysis possibly caused by a poliovirus vaccine. To provide feasible ways to realize or reduce the risk of neurological adverse events caused by vaccines, we further provide a mini-review of the literature of vaccination associated with neurological adverse events. This revealed that oral poliomyelitis vaccine use exclusively and type 2 serotype poliomyelitis vaccine virus were the risk factors for VAPP. The combination vaccine was associated with an increased risk of ADEM and FS following immunization when compared with the administration of vaccines separately. Even though cases have been reported that vaccination may be a trigger of anti-NMDARe and GBS, there is no direct evidence to prove that vaccination increased the risk of GBS and anti-NMDARe.
No takes yet. Share an insight, caveat, or question.
Tian et al. (2019) conducted a case report in Acute flaccid paralysis (n=1). Poliovirus vaccine was evaluated on Neurological adverse events.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: